Company / Operating Cash Flow
KIORA PHARMACEUTICALS INC Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$8.6M
FY2025
5-year range
-$10.8M / $8.6M
FY2021-FY2025
Trend
+189.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has fluctuated over the past 8 years, ranging from -$11M in FY2019 to $9M in FY2025.
Based on SEC 10-K filings.
$9M in FY2025.
Improved from -$7M to $9M over the past 4 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow increased 189.6% year-over-year.
- Lowest operating cash flow in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -5.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.6M | +189.6% |
| FY2024 | -$9.6M | -30.6% |
| FY2021 | -$7.3M | +10.3% |
| FY2020 | -$8.2M | +24.8% |
| FY2019 | -$10.8M | -67.7% |
| FY2018 | -$6.5M | +23.1% |
| FY2017 | -$8.4M | -88.7% |
| FY2016 | -$4.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026